Fact-checked by Grok 2 weeks ago

Carbonic anhydrase

Carbonic anhydrase (CA; EC 4.2.1.1) is a family of ubiquitous metalloenzymes, primarily containing at their , that catalyze the reversible hydration of (CO₂) to ion (HCO₃⁻) and a proton (H⁺). This reaction, which occurs at a rate up to a million times faster than the uncatalyzed process, is fundamental to transport, regulation, and various biosynthetic pathways across all domains of life. The enzymes belong to eight distinct genetic families (α, β, γ, δ, ζ, η, θ, and ι), with structural and mechanistic differences among them, though all share the core catalytic function involving a metal-bound attacking CO₂. In vertebrates, the predominant α-class includes at least 16 isoforms in humans, such as cytosolic CA II and membrane-bound CA IV, each exhibiting tissue-specific expression and roles in processes like erythrocyte CO₂ transport, renal acid-base , and aqueous humor formation in the eye. Beyond their primary activity, CAs display catalytic promiscuity, hydrolyzing esters, aldehydes, and other substrates, and have been implicated in bacterial regulation and . Carbonic anhydrases are structurally characterized by a central β-sheet core surrounding a conical active-site , approximately 15 Å deep, where the ion is coordinated by three residues (histidines in α-CAs) and a molecule that deprotonates to form the reactive . Their physiological importance extends to respiration, where they facilitate the in , and to disease contexts, serving as therapeutic targets for (via CA II inhibitors like ) and cancer, where isoforms like CA IX promote tumor and . Recent discoveries, such as the ι-class in diatoms, highlight ongoing evolutionary and biotechnological potential for CO₂ capture and .

Overview

Definition and Catalyzed Reaction

Carbonic anhydrase (CA) is a family of zinc-dependent metalloenzymes that catalyze the reversible interconversion of and into ion and a proton. The enzyme is classified under EC 4.2.1.1 and plays a crucial role in facilitating this fundamental reaction essential for acid-base balance and across diverse organisms. The catalyzed reaction is represented by the equation: \text{CO}_2 + \text{H}_2\text{O} \rightleftharpoons \text{HCO}_3^- + \text{H}^+ This interconversion operates in both directions: the forward involves the of CO₂ to form , while the reverse direction entails the of to release CO₂. The position of the is -dependent, governed by the Henderson-Hasselbalch equation, where at physiological values above the pKₐ of (approximately 6.1 at 37°C), predominates over dissolved CO₂, with a of about 20:1 at 7.4. Carbonic anhydrase was first identified in 1932 by Norman U. Meldrum and Francis J. W. Roughton, who isolated the from red cells and demonstrated its ability to accelerate CO₂ hydration. Their marked the initial recognition of this enzyme as a key in for expediting the transport and release of CO₂.

Biological and Physiological Importance

Carbonic anhydrase (CA) is a ubiquitous metalloenzyme present in virtually all domains of life, from prokaryotes such as and to eukaryotes including , animals, and fungi, where it exists in multiple isoforms adapted to diverse cellular environments. These isoforms, often exceeding a dozen in higher organisms like humans, enable the enzyme to perform specialized functions while sharing a core catalytic role in the reversible hydration of (CO₂) to (HCO₃⁻) and protons. By accelerating this reaction up to 10⁶-fold over the uncatalyzed rate, CA ensures efficient CO₂ management, which is critical for maintaining metabolic . The physiological significance of CA spans fundamental life processes, including respiration in animals, where it supports rapid CO₂ elimination to prevent acidosis, and photosynthesis in plants and algae, where it concentrates CO₂ at the site of ribulose-1,5-bisphosphate carboxylase/oxygenase () to enhance carbon fixation efficiency. In metabolic pathways, CA contributes to processes like ureagenesis and gluconeogenesis by facilitating bicarbonate availability for carboxylation reactions, thereby linking carbon flux to energy production across organisms. Its broad distribution underscores an indispensable role in adapting to environmental CO₂ fluctuations, from oceanic archaea to terrestrial plants. Evolutionarily, CA represents one of the most ancient enzymes, with γ-class homologs identified in and β-class variants in , suggesting its emergence in ecosystems to mediate early carbon cycling and autotrophy. This conservation across billions of years highlights its foundational contribution to life's ability to harness atmospheric CO₂ for and energy. Mutations causing deficiency in key isoforms, particularly CA II in humans, result in autosomal recessive syndromes characterized by due to impaired , from disrupted acid-base handling in the , and cerebral calcification, illustrating the enzyme's non-redundant roles in skeletal, renal, and neurological . These disorders emphasize how CA's absence disrupts CO₂-bicarbonate equilibrium, leading to systemic failures in pH regulation and ion transport essential for survival.

Molecular Structure

Overall Protein Fold

Carbonic anhydrase enzymes display a variety of three-dimensional architectures that underscore their , enabling the of CO₂ hydration through structurally distinct folds. In the alpha and beta classes, the core consists of a central β-sheet surrounded by α-helices, forming a compact globular domain that positions the within a deep cleft. The gamma class, by contrast, features a unique left-handed β-helix fold, which supports trimeric assembly and formation at subunit interfaces. These proteins are typically composed of 250–300 , yielding a of approximately 30 , and can exist as monomers in many cytosolic forms or as oligomers, such as dimers or trimers, in membrane-associated or prokaryotic variants. The overall fold contributes to , with some carbonic anhydrases from thermophilic extremophiles exhibiting enhanced due to reinforced hydrophobic cores and hydrogen bonding networks, allowing function at temperatures exceeding 80°C.33081-8/fulltext) The first of a carbonic anhydrase was determined in the early 1970s for human carbonic anhydrase II (previously designated as CA C), at a resolution of 2 Å, unveiling a compact β-sheet-dominated fold with seven α-helices encasing the central β-strands. Subsequent structures across classes have confirmed the evolutionary divergence in folds while highlighting conserved geometries that facilitate coordination. Post-translational modifications, such as N-linked in certain membrane-bound isoforms like CA IX and CA XII, influence folding efficiency, stability, and cellular localization without altering the core architecture.

Active Site Configuration and Metal Ion Role

The of carbonic anhydrase is a conical cavity approximately 15 deep, featuring a central (Zn²⁺) that coordinates the catalytic chemistry. In the alpha class, exemplified by human carbonic anhydrase II (CA II), the Zn²⁺ adopts a tetrahedral geometry, bound to the imidazole nitrogen atoms of three conserved residues—His94, His96, and His119—and a fourth consisting of a molecule or depending on . This coordination environment positions the zinc-bound water/ for nucleophilic attack on the . Surrounding the zinc center, key residues such as Thr199 and Glu106 form a hydrogen-bonding network with the bound /, stabilizing the and orienting it for while facilitating . The also includes a hydrophobic pocket lined by residues like Val121, Val143, and Leu198, which accommodates the nonpolar CO₂ and promotes its diffusion into the reactive region. The zinc ion plays a pivotal role in modulating the of the bound from approximately 15.7 (free ) to around 7, generating a zinc-bound at physiological that is essential for efficient CO₂ hydration. This shift arises from the electrostatic stabilization provided by the positively charged Zn²⁺ and the protein environment, enabling the enzyme's high turnover rates. Structural details of the active site have been elucidated through and (EXAFS) spectroscopy, revealing average Zn-N () bond lengths of 1.98–2.02 and Zn-O (/) distances of 2.10–2.15 in CA II. These measurements confirm the tetrahedral coordination and provide insights into the electronic environment influencing reactivity. While is the predominant metal cofactor across carbonic anhydrase classes, rare alternatives exist in certain bacterial and archaeal forms; for instance, substitutes for in delta-class enzymes from diatoms like Thalassiosira weissflogii, and iron serves as the native cofactor in gamma-class enzymes from thermophila. These substitutions maintain catalytic function but are adapted to specific environmental metal availabilities.

Catalytic Mechanism

Reaction Overview and Kinetics

Carbonic anhydrase catalyzes the reversible hydration of CO₂ to and a proton, following Michaelis-Menten with high efficiency, particularly in the α-class isoform CA II, which serves as a for enzymatic performance. For CA II, the (k_cat) reaches approximately 1.3 × 10⁶ s⁻¹ at pH 7.5 and 37°C, making it one of the fastest known enzymes and approaching the diffusion limit for substrate binding. The Michaelis constant (K_m) for CO₂ is low, around 10 mM, indicating high affinity and specificity for the substrate under physiological conditions where CO₂ concentrations are typically much lower. This combination of parameters enables CA II to process substrates at near-maximal rates even at subsaturating concentrations, underscoring its role in rapid metabolic flux. The achieves a rate enhancement of about 10⁷-fold compared to the uncatalyzed reaction, transforming a kinetically sluggish process into one suitable for biological timescales. The uncatalyzed of CO₂ at 7 and 25°C proceeds with a pseudo-first-order rate constant of approximately 0.037 s⁻¹, limited by the formation of the involving water attack on CO₂. In contrast, CA II accelerates this to 10⁶ s⁻¹, effectively overcoming the activation barrier through metal ion coordination and residue stabilization, without altering the of the reaction. The catalytic activity of carbonic anhydrase exhibits dependence, with optimal performance in the physiological range of 7-8, displaying a bell-shaped profile that reflects the states of key residues. At lower , protonation of the zinc-bound reduces nucleophilicity, while at higher , of proton shuttle residues like His64 impairs product release; the curve peaks where both species are optimally balanced for . Isotope exchange studies using ¹³C and ¹⁸O have elucidated rate-limiting steps, confirming that proton transfer from the often governs overall turnover in efficient isoforms like CA II. For instance, ¹⁸O exchange kinetics reveal multiple proton-transfer events contributing to the observed k_cat, with the enzyme's efficiency deriving from a of shuttles that minimize this limitation, while ¹³C effects highlight CO₂ binding as diffusion-controlled.

Detailed Proton Transfer and Hydration Steps

The catalytic mechanism of carbonic anhydrase proceeds via a ping-pong bi-bi pathway, where the alternates between two states to facilitate the reversible of CO₂ to HCO₃⁻ and H⁺. In the first phase, a zinc-bound hydroxide ion (Zn-OH⁻) acts as a , attacking the carbon atom of CO₂ to form a adduct (Zn-HCO₃⁻) with a rate constant approaching 10⁶ s⁻¹. This step occurs within the hydrophobic pocket near the , where CO₂ binds loosely without direct coordination to the metal. Following the , the ion is released from the , displacing it into solution and leaving a -bound (Zn-H₂O). This deprotonated then requires regeneration of the active Zn-OH⁻ for the next , which involves a critical intramolecular proton transfer. The proton from Zn-H₂O is shuttled to the bulk solvent via , a conserved residue positioned at the entrance. His64 rotates between inward and outward conformations, facilitating proton acceptance from the active site via a hydrogen-bonded network of solvent and subsequent release to the exterior. Key intermediates in this process include the Zn-OH⁻ nucleophile, which is stabilized by the Lewis acidity of the Zn²⁺ ion, the transient bicarbonate adduct bound bidentately to zinc, and the protonated form of His64 (His64H⁺). The tautomerism of His64, with equal populations of its Nδ1-H and Nε2-H forms, enables efficient proton relay without requiring large-scale conformational shifts, occurring through a concerted mechanism involving water bridges at neutral pH. The rate-limiting step varies depending on conditions but often involves the proton transfer mediated by His64, particularly in the regeneration of Zn-OH⁻, with barriers around 10.4 kcal/mol as determined by (DFT) calculations. These quantum mechanical studies, using like B3LYP, reveal transition states for proton shuttling via Grotthuss-like water chain mechanisms and the subsequent , highlighting low barriers (∼4.4 kcal/mol) for the CO₂ attack itself compared to proton handling. In some cases, product release or can become limiting, underscoring the enzyme's optimization for rapid turnover.

Classification into Families

Alpha-Carbonic Anhydrases

Alpha-carbonic anhydrases (α-CAs) represent the predominant class of carbonic anhydrases in vertebrates, characterized by a distinctive protein fold consisting of a central twisted β-sheet typically comprising 8 to 10 strands, surrounded by α-helices that form a conical housing the . This architecture facilitates the coordination of a ion at the , essential for , and distinguishes α-CAs from other classes through their right-handed β-α-β arrangement within the core . In humans, 15 α-CA isoforms have been identified (CA I–XV), of which 12 are catalytically active, varying in subcellular localization, tissue distribution, and kinetic properties. Among the key isoforms, CA II is a highly efficient cytosolic abundant in red blood cells (RBCs), where it accelerates CO₂ hydration to support rapid during . CA IX, a transmembrane isoform, is uniquely induced under hypoxic conditions via hypoxia-inducible factor-1 (HIF-1) and is overexpressed in various tumors, contributing to regulation in the . Another notable isoform, CA IV, is GPI-anchored to the extracellular surface and prominently expressed in the lungs and kidneys, aiding in across endothelial barriers. Expression of α-CAs is ubiquitous across human tissues but exhibits isoform-specific patterns, such as CA IV's enrichment in pulmonary to facilitate alveolar . Mutations in the CA II gene lead to carbonic anhydrase II deficiency syndrome, an autosomal recessive disorder also known as marble brain disease, characterized by , , and intracranial calcifications due to impaired acid-base . Recent advances include the computational design of selective CA IX inhibitors, such as pharmacophore-based screening of small-molecule libraries yielding compounds with high affinity for the tumor-associated isoform while sparing off-target CAs, offering promise for targeted cancer therapies.

Beta- and Gamma-Carbonic Anhydrases

Beta-carbonic anhydrases (β-CAs) represent a distinct class of zinc metalloenzymes characterized by a left-handed β-helix fold, consisting of twisted parallel β-sheets that form the core structure of each monomer. These enzymes are prevalent in prokaryotes, plants, algae, and some archaea, where they catalyze the reversible hydration of CO₂ to bicarbonate and protons. In plants, β-CAs are commonly localized in chloroplasts, such as the Cab-type β-CA in Pisum sativum, which plays a crucial role in photosynthesis by facilitating CO₂ concentration near Rubisco, thereby enhancing carbon fixation efficiency in CO₂-limited environments. The functional unit of many β-CAs is a dimer, with the active site formed at the interface between subunits; the catalytic zinc ion is coordinated by two cysteines, one aspartate, and one histidine, enabling a pH-dependent conformational switch that activates the enzyme at higher pH values. Catalytic turnover rates (k_cat) for β-CAs can reach up to 4 × 10⁵ s⁻¹, approaching the efficiency of some α-class enzymes. Evolutionarily, β-CAs trace their origins to ancient prokaryotic lineages, where they were co-opted into CO₂-concentrating mechanisms, such as carboxysomes in and , to optimize activity by maintaining elevated levels. This adaptation likely preceded the endosymbiotic event that integrated prokaryotic ancestors into chloroplasts, allowing β-CAs to support photosynthetic carbon assimilation in higher . Unlike α-CAs, β-CAs uniquely exhibit in some variants, where substrate binding modulates activity through proton loss and conformational changes. Gamma-carbonic anhydrases (γ-CAs) form another evolutionarily unrelated class, featuring a compact left-handed parallel β-helix fold with three strands per turn, distinct from the more extended helix in β-CAs. The prototype γ-CA, from the archaeon thermophila, functions as a homotrimer with active sites at subunit interfaces, where a (or sometimes iron) ion is coordinated by three residues. These enzymes are primarily found in and some , contributing to by aiding acetate metabolism through CO₂ hydration, which helps maintain and provides for biosynthetic pathways. Catalytic activity is notably slower than in β-CAs, with k_cat values exceeding 10⁴ s⁻¹ but limited by inefficient proton transfer. A key mechanistic difference in γ-CAs is the absence of a histidine-based proton shuttle, as seen in α-CAs; instead, proton transfer relies on a network of glutamate residues, such as , which facilitates but results in lower overall efficiency compared to the histidine-mediated shuttling in other classes. This structural variation underscores the of carbonic anhydrases across domains of life, where γ-CAs represent an ancient adaptation suited to extremophilic environments like those of methanogenic .

Other Classes (Delta, Zeta, Eta, Iota)

The class of carbonic anhydrases (δ-CAs) is predominantly found in , serving as key extracellular enzymes in carbon acquisition under low-CO₂ conditions. These enzymes are cambialistic, capable of incorporating either (ZnII) or (FeII) as the catalytic , allowing adaptation to varying metal availabilities in environments. The δ-CA from the diatom Thalassiosira weissflogii, designated TweCA, is a monomeric protein comprising 281 with a of approximately 32 kDa, featuring a ZnII coordinated in a manner akin to α-CAs but with distinct phylogenetic positioning. TweCA exhibits efficient CO₂ activity, achieving a (kcat) of 1.3 × 105 s-1 and a second-order rate constant (kcat/KM) of 3.3 × 107 M-1 s-1, while lacking activity toward 4-nitrophenyl acetate. Notably, TweCA displays high , retaining about 40% activity after incubation at 80°C for 30 minutes, which supports its role in the dynamic . The zeta class (ζ-CAs) occurs in marine algae, such as species of Porphyra and diatoms like Phaeodactylum tricornutum, as well as in certain bacteria, where they contribute to intracellular CO₂ concentration mechanisms. Unlike most CA classes, ζ-CAs lack the canonical histidine ligands for metal coordination, instead employing two cysteine residues and one histidine residue to bind the ZnII ion within a left-handed β-helix fold, which facilitates a unique catalytic pocket. This atypical coordination enables efficient interconversion of CO₂ and HCO₃-, with kcat values reaching up to 106 s-1 in algal isoforms. Beyond CO₂ hydration, ζ-CAs demonstrate CS₂ hydrolase activity, hydrolyzing carbon disulfide to COS and H₂S, suggesting broader roles in sulfur metabolism for microbial sulfur-oxidizing pathways. Their presence in extremophilic bacteria further underscores adaptability to low-pH or high-sulfide environments. The eta class (η-CAs), first characterized in the mid-2010s, has been identified in and protozoan pathogens, featuring a protein fold that closely resembles α-CAs but with a distinctive architecture. The ZnII ion in η-CAs is coordinated by two residues and one residue, along with a / , deviating from the three- of canonical classes and imparting specificity to anion inhibition profiles. This unique geometry supports robust CO₂ hydration without accompanying function, with inhibitors showing moderate potency compared to α-CAs. η-CAs' bacterial representatives, such as those in and pathogenic species, highlight their potential in microbial and as targets for antibacterial therapies. Phylogenetic analyses of signal peptides indicate predominant periplasmic localization in , aiding extracellular CO₂ capture. The theta class (θ-CAs), discovered in 2016, is found in marine diatoms such as Phaeodactylum tricornutum, where it localizes to the thylakoid lumen and plays a critical role in photosynthesis. θ-CAs belong to the Cys-Gly-His-rich family and feature a zinc-binding site coordinated by two cysteine residues (Cys307, Cys387), one aspartate (Asp309), and two histidine residues (His349, His363). The enzyme exhibits CO₂ hydration activity of approximately 30.9 Wilson-Anderson units (WAU) per mg protein and bicarbonate dehydration activity of 42.2 WAU per mg protein, with moderate esterase activity. θ-CAs are essential for growth and photosynthetic efficiency, utilizing the thylakoid pH gradient to supply CO₂ to Rubisco and regulate dissolved inorganic carbon/proton equilibria in the lumen. The iota class (ι-CAs), emerging as a distinct group in the early 2020s, was initially discovered through genomic analysis of the marine diatom Thalassiosira pseudonana, where the enzyme LCIP63 functions in CO₂-concentrating mechanisms essential for photosynthesis in low-CO₂ seawater. ι-CAs exhibit a novel fold unrelated to established classes, with the catalytic metal—preferentially Mn2+ but also active with ZnII or Cd2+—coordinated in a geometry that enables high-efficiency hydration, though specific kinetic parameters vary by isoform (e.g., kcat ~105–106 s-1). Subsequent identification in marine and soil bacteria, including Burkholderia territorii (BteCAι), reveals widespread distribution among prokaryotes, suggesting evolutionary convergence for metal flexibility in nutrient-limited niches. These enzymes' potential for alternative mechanisms, such as enhanced anion binding or cofactor promiscuity, positions them for biotechnological applications in carbon capture. Genomic and metagenomic surveys conducted between 2023 and 2025 have expanded understanding of δ-, ζ-, η-, and ι-CA , particularly in extremophiles inhabiting hydrothermal vents and other high-temperature, low-pH environments. These studies identified novel clades and biome-specific variants, revealing higher prevalence of ι-CAs in coastal microbial mats and ζ-CAs in sulfur-rich sediments, with adaptations like altered metal-binding motifs enhancing stability under extreme conditions. For instance, analyses of thermophilic microbiomes uncovered ι-like sequences in archaea-bacteria consortia, emphasizing their role in global carbon cycling and potential for heat-resistant variants. Such findings underscore the untapped microbial of these classes for addressing climate-related challenges.

Physiological Roles

pH Regulation and Acid-Base Balance

Carbonic anhydrase (CA) plays a pivotal role in the , which is essential for maintaining in various tissues by facilitating the interconversion of and to buffer protons. In the and , CA generates ions (HCO₃⁻) that neutralize excess H⁺, preventing acidification of cellular and extracellular fluids. This enzymatic activity supports the rapid production and reabsorption of bicarbonate, ensuring acid-base balance during physiological processes that produce metabolic acids. In the renal proximal tubule, cytosolic CA II and membrane-bound CA IV are critical for reabsorption, accounting for approximately 80-90% of filtered HCO₃⁻ recovery. CA II, comprising about 95% of renal CA activity, catalyzes the intracellular formation of H⁺ and HCO₃⁻ from CO₂ and H₂O, enabling H⁺ secretion via the apical Na⁺/H⁺ exchanger (NHE3) and HCO₃⁻ efflux through the basolateral Na⁺/HCO₃⁻ cotransporter (kNBC1). CA IV, anchored on both apical and basolateral membranes via a (GPI) linkage, accelerates the dehydration of filtered H₂CO₃ to CO₂ on the luminal side and enhances basolateral HCO₃⁻ export, forming functional metabolons with transporters. Defects in CA II, such as in carbonic anhydrase II deficiency syndrome, impair H⁺ secretion and regeneration, leading to proximal and . Similarly, inhibition or absence of CA IV reduces reabsorption efficiency, exacerbating acid-base imbalances. Cytosolic CA isoforms, particularly CA II, are essential for regulation by mitigating acidification from metabolic CO₂ production during and other processes. These enzymes rapidly convert metabolically generated CO₂ to HCO₃⁻ and H⁺, allowing H⁺ extrusion via membrane transporters and maintaining cytosolic near neutrality to support enzymatic functions and prevent metabolic stress. In various types, including neurons and hepatocytes, cytosolic CA activity buffers pH fluctuations, with inhibition leading to slowed pH recovery and altered cellular responses to acid loads. Membrane-associated CA IV can also exhibit intracellular activity, contributing to proton buffering in the of specialized cells like neurons. In gastric parietal cells, CA IV supports (HCl) secretion by facilitating proton production and handling on the cell membranes. Expressed on the basolateral and potentially apical surfaces, CA IV catalyzes CO₂ hydration to supply H⁺ for the H⁺/K⁺- pump and enables HCO₃⁻ extrusion to the bloodstream, preventing intracellular alkalization. This membrane-bound activity, which retains function in acidic environments ( < 4), contributes significantly to stimulated acid secretion, with inhibition reducing H⁺ output by up to 55% in experimental models. Recent studies have explored carbonic anhydrase inhibitors (CAIs) in regulating vascular tone, highlighting their potential beyond traditional uses. Sulfonamide-based CAIs induce vasodilation in cerebral, ocular, and renal vasculatures by modulating local pH and ion transport, increasing blood flow without affecting abdominal vessels; this effect depends on inhibitor lipophilicity and membrane permeability. Coumarin-type CAIs exhibit similar vasodilatory actions on retinal arterioles, suggesting therapeutic applications in vascular pH-related disorders.

Carbon Dioxide Transport and Respiration

Carbonic anhydrase isoforms I and II, predominantly expressed in erythrocytes, catalyze the rapid conversion of carbon dioxide (CO₂) produced by tissues into bicarbonate (HCO₃⁻) and protons (H⁺), enabling efficient CO₂ transport in plasma. This hydration reaction, accelerated by up to 13,000–25,000-fold by these cytosolic enzymes, allows 95% completion within milliseconds, preventing diffusion limitations during gas exchange. The resulting HCO₃⁻ is then exchanged for chloride (Cl⁻) across the erythrocyte membrane via the band 3 anion exchanger (also known as AE1), which operates at a turnover rate of 40,000–50,000 ions per second, facilitating HCO₃⁻ efflux into plasma for systemic transport while maintaining electroneutrality. Approximately 70–80% of total CO₂ is carried as HCO₃⁻ in this form, underscoring the enzyme's critical role in venous return. This process is further enhanced by the Haldane effect, where deoxygenation of hemoglobin in peripheral tissues increases its affinity for H⁺ and CO₂, promoting greater HCO₃⁻ formation; facilitates this linkage by accelerating the interconversion kinetics between CO₂, HCO₃⁻, and H⁺, thereby amplifying overall CO₂ loading capacity by up to 20–30% without the enzyme's slowdown. In the lungs, the reverse occurs: membrane-bound on pulmonary endothelial and alveolar epithelial cells dehydrates incoming HCO₃⁻ to regenerate CO₂, which diffuses into alveoli for exhalation, completing the respiratory cycle with near-complete efficiency. This extracellular isoform ensures rapid reversal of the peripheral hydration, with activity localized to facilitate HCO₃⁻ influx from plasma and H⁺ buffering by oxygenated hemoglobin via the Haldane effect. During exercise, when CO₂ production surges, blood carbonic anhydrase activity upregulates, with studies showing up to a 50% increase in erythrocyte CA levels after two weeks of high-intensity training, supporting faster CO₂ clearance and preventing hypercapnia. This adaptive response enhances isoform expression or activation to match elevated metabolic demands, maintaining ventilatory efficiency. More recently, in obstructive sleep apnea, elevated CA activity correlates with increased arterial HCO₃⁻ levels and hypoxemic burden; pharmacological reduction of CA activity has been linked to amelioration of apnea severity, potentially by lowering HCO₃⁻ accumulation and improving respiratory control.

Inhibitors and Therapeutics

Types of Inhibitors and Their Mechanisms

Carbonic anhydrase (CA) inhibitors are classified based on their chemical nature and binding modes, primarily targeting the enzyme's active site zinc ion or occluding the substrate access channel. The main types include sulfonamides, anions, coumarins, and emerging polypharmacological hybrids, each exhibiting distinct inhibition mechanisms such as competitive, uncompetitive, or non-competitive binding. These inhibitors generally achieve nanomolar to micromolar potencies against human CA isoforms, with selectivity influenced by structural variations. Sulfonamides represent the classical class of CA inhibitors, characterized by a sulfonamide group that binds directly to the zinc ion in the active site. The deprotonated nitrogen of the sulfonamide coordinates to Zn(II), displacing the catalytically essential hydroxide ion (OH⁻) and forming a stable tetrahedral complex that prevents substrate binding. This binding mode results in uncompetitive inhibition with respect to CO₂ hydration, as the inhibitor preferentially associates with the enzyme-substrate complex. Acetazolamide, a prototypical heterocyclic sulfonamide, exemplifies this class with an inhibition constant (Kᵢ) of approximately 12 nM against human CA II (hCA II), highlighting its high affinity. Anions constitute another early-discovered class, acting as inorganic or simple organic inhibitors that directly coordinate to the Zn(II) ion. Monovalent anions such as cyanide (CN⁻) and iodide (I⁻) bind to the zinc in a tetrahedral geometry, replacing the OH⁻ ligand and thereby blocking the nucleophilic attack on CO₂. This coordination leads to uncompetitive inhibition at physiological pH, with nonlinear kinetics observed in Dixon plots for most anions except cyanate. Cyanide, often studied in complexes like Au(CN)₂⁻, exhibits particularly strong binding due to its nucleophilic properties, while iodide shows weaker but pH-dependent inhibition. Coumarins form a newer class of non-zinc-binding inhibitors that operate via a unique prodrug mechanism. These compounds initially bind near the active site entrance, where the enzyme's intrinsic esterase activity hydrolyzes the lactone ring to generate a 2-hydroxycinnamic acid derivative. This activated form then reorients to occlude the active site channel, preventing substrate entry in a non-competitive manner. Coumarins demonstrate remarkable isoform selectivity, potently inhibiting tumor-associated isoforms like CA IX and XII (Kᵢ values in the nanomolar range) while sparing cytosolic CA I and II, making them valuable for targeted applications. Recent advances in polypharmacology have yielded dual CA inhibitors that simultaneously target CA and other enzymes, enhancing therapeutic potential through multifaceted binding. For instance, hybrids designed to inhibit CA alongside monoamine oxidases (MAO) or cholinesterases (ChE) exhibit competitive zinc-binding at CA while modulating secondary targets via distinct pharmacophores, with 2024-2025 developments focusing on brain-penetrant compounds for neurodegenerative disorders (IC₅₀ < 100 nM for hCA II). In 2024, novel hydantoin-phthalimide hybrids were synthesized via condensation of activated phthalimides with 1-aminohydantoin, acting as potent, selective inhibitors of isoforms CA VI, VII, and IX (Kᵢ values 10-50 nM) through zinc coordination similar to sulfonamides. These innovations underscore ongoing efforts to refine inhibition mechanisms for isoform-specificity.

Clinical Applications and Emerging Therapies

Carbonic anhydrase inhibitors (CAIs) have established clinical applications in ophthalmology, particularly for glaucoma management, where topical formulations such as dorzolamide and brinzolamide reduce intraocular pressure by decreasing aqueous humor production. These agents are administered as eye drops, typically two to three times daily, and are often used in combination with other antiglaucoma therapies to enhance efficacy in patients with open-angle glaucoma or ocular hypertension. Systemic CAIs like acetazolamide may also be employed in refractory cases or congenital glaucoma to lower intraocular pressure prior to surgery. In neurology, acetazolamide serves as an adjunctive therapy for certain epilepsy syndromes, including absence seizures and familial periodic paralysis with epilepsy, by modulating neuronal pH and excitability to prevent and control seizures. It is also utilized for migraine prophylaxis, particularly in conditions like CADASIL-associated migraine with aura, where it reduces attack frequency and severity, though the exact mechanism remains under investigation. In oncology, selective inhibitors targeting carbonic anhydrase IX (CAIX), such as SLC-0111, are being explored for hypoxic tumors, where CAIX overexpression supports tumor survival and resistance to therapy. SLC-0111, currently in Phase Ib/II clinical trials as of 2025, sensitizes cancer cells to chemotherapeutics like temozolomide and dacarbazine in glioblastoma and melanoma models, respectively, by disrupting pH regulation in the tumor microenvironment. This approach aims to curtail tumor growth and metastasis in cancers like gastric and renal cell carcinoma. Emerging therapies highlight CA modulation's potential beyond traditional indications. A 2024 study demonstrated that CA inhibition ameliorates tau toxicity in Alzheimer's disease models by enhancing tau secretion and reducing intracellular aggregation, with no observed toxicity in treated mice, suggesting repurposing of existing CAIs like acetazolamide. In sleep apnea, 2025 clinical data link reduced CA activity to amelioration of obstructive sleep apnea (OSA), with the CAI sultiame showing dose-dependent improvements in apnea-hypopnea index and ventilatory stability in Phase II trials, positioning it as a novel oral therapy. A 2024 review underscores CA's role in vascular tone regulation, where CAIs influence endothelial and smooth muscle function to modulate blood flow, offering therapeutic promise for cardiovascular disorders. Dual-target CAIs represent an advancing strategy for multifactorial diseases, combining CA inhibition with other pathways to enhance outcomes in cancer and inflammation; a 2025 analysis highlights their potential to overcome resistance and reduce side effects by addressing tumor acidosis and inflammatory cascades simultaneously. Systemic CAI use is limited by side effects, including transient diuresis from renal bicarbonate loss and paresthesia manifesting as tingling in extremities or perioral regions, which occur due to metabolic acidosis and electrolyte shifts. These effects often necessitate dose adjustments or topical alternatives to improve tolerability.

Biotechnological Applications

Carbon Capture and Sequestration

Carbonic anhydrase (CA) enzymes are employed in bioreactors to accelerate the hydration of CO₂ to bicarbonate (HCO₃⁻), facilitating its mineralization into stable carbonates such as (CaCO₃) in the presence of divalent cations like Ca²⁺. This process mimics natural biomineralization, where CA catalyzes the rate-limiting step of CO₂ hydration, enabling rapid precipitation of from CO₂-laden solutions containing . In experimental setups, immobilized CA on gas-permeable membranes within bubble-column reactors has demonstrated enhanced CO₂ sequestration, with precipitation rates increasing significantly compared to uncatalyzed systems, producing up to 920 mg of per mg of enzyme over multiple cycles. For post-combustion capture, CA is immobilized on membranes or hollow fibers to enhance flue gas scrubbing, particularly in alkaline absorbents like or . These configurations promote CO₂ absorption by accelerating bicarbonate formation, with evolved CA variants achieving up to 25-fold increases in mass transfer coefficients (from 1.6 to 39 kmol·m⁻³·atm⁻¹·h⁻¹) in 2.1 M solutions. Immobilization methods, such as covalent attachment to magnetic nanoparticles or encapsulation in chitosan-alginate beads, retain 50–60% activity after 10–22 cycles, reducing absorber column sizes by over 90% relative to conventional amine systems. Key challenges in deploying CA for carbon capture and sequestration (CCS) include enzyme stability under high temperatures (up to 107 °C), alkaline pH (>10), and chemical inhibitors in flue gases, as well as high production costs limiting . has addressed these by introducing mutations (e.g., 36 sites altered in variants like DvCA8.0, including A56S and A84Q) that extend from 15 minutes to 14 weeks at 50 °C, a 4,000,000-fold stability gain over wild-type . Despite these advances, enzyme and matrix destabilization by bicarbonates persist, necessitating further for cost-effective, recyclable systems. Field trials have validated CA's efficacy, including a 2014 pilot at the National Carbon Capture Center using evolved DvCA, which sustained 60–70% CO₂ capture over 60 hours across absorption-desorption cycles at 25–87 °C. More recently, Veolia's 2024 world-first trial in the UK applies CA enzymes combined with silicate rocks for enhanced weathering on agricultural land, accelerating natural CO₂ mineralization to bicarbonate and silicates for permanent storage. In 2023, Saipem launched Bluezyme, a biomimetic nanomaterial-based CA solution for industrial CO₂ capture, demonstrating thermo- and alkali-stability in harsh conditions to support scalable CCS deployment. CA-assisted CCS holds potential to contribute to IPCC targets by enabling gigaton-scale annual CO₂ capture, aligning with the median 196 Gt of fossil CO₂ cumulatively captured and stored across low-overshoot 1.5 °C pathways (AR6 WG3), through energy-efficient processes that cut desorption energy by up to fourfold and environmental impacts by 50–54% compared to traditional methods.

Biomimetic and Industrial Uses

Biomimetic approaches to (CA) have focused on synthetic catalysts that replicate the enzyme's to accelerate CO₂ hydration, facilitating downstream conversion to value-added products such as . Zinc-cyclen complexes, for instance, serve as effective mimics by coordinating Zn(II) ions within a macrocyclic to catalyze CO₂ into at rates approaching natural CA efficiency under mild conditions. These systems have been integrated into ionic liquids to enhance and , enabling continuous CO₂ processing for potential pathways. A bifunctional Zn(cyclen)²⁺ variant, for example, boosts CO₂ capture rates by 84% while suppressing competing evolution reactions during electrochemical reduction, supporting integrated conversion to or other C1 . In industrial settings, CA enzymes aid pH control in processes by rapidly converting CO₂ to , mitigating and in systems. For , CA accelerates CO₂ in beverages, enabling efficient without excessive or , as demonstrated in membrane-based reactors that produce sparkling and soft drinks. In biofuel production, CA enhances CO₂ fixation in photosynthetic organisms like and , increasing yields by up to 30-50% through improved carbon flux; for example, expression of CA II in algal chloroplasts has boosted growth rates for precursors. Enzyme engineering via has produced thermostable CA variants suitable for harsh industrial environments. A β-class CA from a thermophilic source was iteratively mutated to achieve over 4,000,000-fold greater stability at temperatures exceeding 80°C and alkaline levels up to 10, retaining full activity after prolonged exposure to impurities. Similarly, CA from Thermosynechococcus elongatus exhibits inherent up to 60°C, with in E. coli yielding enzymes comparable to native forms for high-temperature applications. Recent advances from 2023-2025 highlight nanomaterials integrated with CA for enhanced CO₂ conversion. Immobilization of CA on ZnO nanoparticles improves thermal stability (optimal pH shifted to 8.5) and reusability, retaining 85% activity over five cycles while catalyzing 476 mg CaCO₃ formation per mg enzyme, accelerating mineralization for industrial scalability. Zinc single-atom nanozymes mimicking CA achieve over 91% CO₂ conversion efficiency in hydrated systems, outperforming traditional carbon supports by facilitating rapid bicarbonate formation. Dual-function enzyme systems, such as CA paired with formate dehydrogenase in metal-organic frameworks, enable cascade reactions converting CO₂ directly to formate with high selectivity under ambient conditions. As of 2025, CA enzymes are increasingly integrated into direct air capture (DAC) systems, enhancing efficiency in low-concentration CO₂ environments. Novozymes has patented heat-stable CA formulations for potential use in beverage , utilizing immobilized enzymes in membrane contactors to achieve uniform CO₂ infusion at low energy costs. These applications underscore CA's versatility beyond natural catalysis, where the enzyme's zinc-histidine coordination drives reversible CO₂ hydration.

References

  1. [1]
    Carbonic Anhydrases: Versatile and Useful Biocatalysts in ... - MDPI
    Sep 3, 2020 · Carbonic anhydrases (CAs) are metalloenzymes that catalyze the hydration of CO2 to bicarbonate and a proton, and are effective catalysts.
  2. [2]
    Carbonic Anhydrase - an overview | ScienceDirect Topics
    Carbonic anhydrase is an enzyme responsible for the metabolism of bicarbonate and is considered a tumoral micro-environment acidity and hypoxia regulator.
  3. [3]
    EC 4.2.1.1 - IUBMB Nomenclature
    IUBMB Enzyme Nomenclature. EC 4.2.1.1. Accepted name: carbonic anhydrase. Reaction: H2CO3 = CO2 + H2O. Other name(s): carbonate dehydratase; anhydrase; ...
  4. [4]
    Role of Carbonic Anhydrases and Inhibitors in Acid–Base Physiology
    Carbonic anhydrases (CAs) catalyze a reaction fundamental for life: the bidirectional conversion of carbon dioxide (CO2) and water (H2O) into bicarbonate ...
  5. [5]
    Carbonic anhydrase is an ancient enzyme widespread in prokaryotes
    Here we show that carbonic anhydrase is widespread in the Archaea and Bacteria domains, and is an ancient enzyme. The occurrence in chemolithoautotrophic ...
  6. [6]
    Carbonic anhydrases in plants and algae - Wiley Online Library
    Feb 17, 2004 · Carbonic anhydrases catalyse the reversible hydration of CO2, increasing the interconversion between CO2 and HCO3− + H+ in living organisms.
  7. [7]
    Thermodynamics of carbonic anhydrase catalysis. A ... - PubMed - NIH
    The uncatalyzed reactions are significantly affected by temperature, 30- to 40-fold rate enhancements being observed from 0 degrees to 37 degrees C. The enzyme- ...
  8. [8]
    Plant Carbonic Anhydrases: Structures, Locations, Evolution, and ...
    Sep 16, 2016 · Carbonic anhydrases (CAs) play essential roles in all photosynthetic organisms. In cyanobacteria, CAs located in the carboxysome are required ...
  9. [9]
    Carbonic Anhydrase - an overview | ScienceDirect Topics
    CAs have involvement in many physiological roles like gluconeogenesis, ureagenesis, fluid secretion, acid/base balance, and thus pH regulation, gastric acid ...
  10. [10]
    Expression and localization of two β-carbonic anhydrases ... - Frontiers
    Jan 15, 2025 · β-type CAs play a key role in the CO2-concentrating mechanism, thereby contributing to efficient photosynthesis in the C4 plants in addition to ...
  11. [11]
    A Novel Evolutionary Lineage of Carbonic Anhydrase (ε Class) Is a ...
    This CA (CcaA) is a member of the β class, one of three independent evolutionary lineages (α, β, and γ) that are widespread among the domains Bacteria, Archaea, ...
  12. [12]
    Resurrecting ancestral genes in bacteria to interpret ancient ...
    Nov 13, 2017 · We assess how carbonic anhydrase proteins meet our selection criteria for reconstructing ancient biosignatures in the laboratory, which we term palaeophenotype ...
  13. [13]
    Carbonic Anhydrase II Deficiency in 12 Families with the Autosomal ...
    Jul 18, 1985 · A deficiency of carbonic anhydrase II is the enzymatic basis for the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral ...
  14. [14]
    Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal ...
    The carbonic anhydrase II (CA II) deficiency syndrome is an autosomal recessive disorder that produces osteopetrosis, renal tubular acidosis, and cerebral
  15. [15]
    Carbonic Anhydrase II Deficiency: A Rare Case of Severe ... - Frontiers
    Jul 30, 2018 · The deficiency of carbonic anhydrase II causes a moderate form, presenting classically as a triad of osteopetrosis, renal tubular acidosis (RTA) ...
  16. [16]
    The molecular structures of the three carbonic anhydrases - PMC - NIH
    (1972) Crystal structure of human carbonic anhydrase C. Nature New Biol., 235, 131–137. [DOI] [PubMed] [Google Scholar]; Liljas A., Håkansson, K., Jonsson ...
  17. [17]
    Full article: Structural annotation of human carbonic anhydrases
    Overall, most hCA isoforms (except hCA VI, IX and XII) exist in monomeric forms composed of seven right handed α-helices, and a twisted β-sheet formed by 10 β- ...Structure And Function Of... · Table 3. Structural Main... · Stability Of α-Cas
  18. [18]
    The molecular structures of the three carbonic anhydrases: EMBO ...
    (1972) Crystal structure of human carbonic anhydrase C. Nature New Biol., 235, 131–137. Go to Citation. Google Scholar. Liljas, A., Håkansson, K., Jonsson ...
  19. [19]
    Thermostable Carbonic Anhydrases in Biotechnological Applications
    Carbonic anhydrases are ubiquitous metallo-enzymes which catalyze the reversible hydration of carbon dioxide in bicarbonate ions and protons.
  20. [20]
    Thermostability enhancement of the α-carbonic anhydrase from ...
    They are classified into seven genetically distinct families and catalyse the hydration reaction of carbon dioxide to bicarbonate and protons, as well as the ...
  21. [21]
    Human carbonic anhydrases and post-translational modifications
    N-linked glycosylation is an enzyme-catalysed process involving the attachment of an oligosaccharide (also referred to as glycan) to the amide nitrogen of ...
  22. [22]
    Revisiting Zinc Coordination in Human Carbonic Anhydrase II - PMC
    Oct 3, 2012 · Carbonic anhydrase (CA) is a well-studied, zinc-dependent metalloenzyme that catalyzes the hydrolysis of carbon dioxide to the bicarbonate ion.
  23. [23]
    Structural study of X-ray induced activation of carbonic anhydrase
    Key features of the active site (Fig. 1) include a zinc ion coordinated tetrahedrally by 3 histidine residues (His-94, His-96, and His-119) and a water ...
  24. [24]
    Elucidating the role of metal ions in carbonic anhydrase catalysis
    Sep 11, 2020 · The active site zinc ion is tetrahedrally coordinated to the protein by the imidazole groups of three histidine residues, with the remaining ...
  25. [25]
    Importance of the conserved active-site residues Tyr7, Glu106 and ...
    Feb 1, 1993 · These results suggest important roles for Thr199 and Glu106 in carbonic anhydrase catalysis. The mutant with Asp106 is almost fully active.
  26. [26]
    Insights into the function of the zinc hydroxide-Thr199-Glu106 ...
    The exact functional role of the zinc hydroxide (water)-Thr199-Glu106 hydrogen bond network in the carbonic anhydrases is unknown. However, from the results ...
  27. [27]
    Binding of substrate CO2 to the active site of human carbonic ...
    Three potential CO2 binding sites have been located. The first is at the active-site hydrophobic pocket (the catalytically productive site), where CO2 is ...
  28. [28]
    Sequestration of Carbon Dioxide by the Hydrophobic Pocket of ... - NIH
    Combined, these results suggest that CO2 would bind in a way as to interact ephemerally with the hydrophobic half of the active site. The hydrophilic half also ...
  29. [29]
    pK a Analysis for the Zinc-Bound Water in Human Carbonic ...
    In CAII, the zinc-bound water has a pKa of nearly 7, which makes the proton transfer to the acceptor, His 64, nearly thermoneutral. This pKa match is likely of ...Introduction · III. Results and Discussion · IV. Concluding Remarks · References
  30. [30]
    Functional characterization of human carbonic anhydrase II variants ...
    Substitution of the His zinc ligands with negatively charged amino acids both increases the pKa of the zinc-bound water by > or = 1.6 pH units, confirming ...
  31. [31]
    The Complex Relationship between Metals and Carbonic Anhydrase
    Jan 19, 2016 · The β-carbonic anhydrases are dimers, tetramers or octamers and are expressed mainly in fungi, bacteria, archaea, algae and chloroplasts of ...
  32. [32]
    The γ Class of Carbonic Anhydrases - PMC - NIH
    The finding that iron is the physiologically relevant metal in Cam ... Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms.
  33. [33]
    A new widespread subclass of carbonic anhydrase in marine ...
    Apr 25, 2019 · All CAs require a metal ion for their catalysis that is most frequently zinc. However, the prokaryote Methanosarcina thermophila, contains a ...Methods · Carbonic Anhydrase And... · Results
  34. [34]
    Thermodynamics of carbonic anhydrase catalysis. A comparison ...
    The 37 degrees C hydration kcat, at pH 7.5, is 13 X 10(5) s-1 for isozyme C and 0.71 X 10(5) s-1 for isozyme B. Km, for hydration, is 10 mM for C and 5 mM ...
  35. [35]
    Rate constant of the reaction H2CO3→H2O+CO2 - Generic
    The rate constant for the reaction H2CO3→H2O+CO2 in the absence of carbonic anhydrase is 0.037 Sec^-1.
  36. [36]
    Carbonic anhydrase catalyzed hydration studied by carbon-13 and ...
    [35] Carbonic anhydrase: Oxygen-18 exchange catalyzed by an enzyme with rate-contributing Proton-transfer steps. ... The Rate-Limiting Event in the Depletion of ...
  37. [37]
  38. [38]
  39. [39]
  40. [40]
  41. [41]
    Structure of α-carbonic anhydrase from the human pathogen ...
    The fold of the HpαCA monomer corresponds to that of the classical α-CA, characterized by a central ten-stranded β-sheet surrounded by three α-helices and by ...
  42. [42]
    Human carbonic anhydrases and post-translational modifications
    Fifteen isoforms have been identified so far, among which only twelve are catalytically active (CA I–IV, VA–VB, VI–VII, IX, and XII–XIV), whereas three are ...
  43. [43]
    Evaluating the role of carbonic anhydrases in the transport of HCO3
    The soluble enzyme carbonic anhydrase II (CAII) plays an important role in CO 2 influx and efflux by red blood cells (RBCs).
  44. [44]
    Carbonic Anhydrase (CA IX) Expression, a Potential New Intrinsic ...
    These studies provide clinical evidence that CA IX expression is up-regulated in hypoxic human cervical tumors and is associated with a poor prognosis. CA IX ...
  45. [45]
    Probing the Surface of Human Carbonic Anhydrase for Clues ... - NIH
    Humans express 15 different isoforms, 12 of which are catalytically active and differ in their enzymatic efficiency. These isoforms also differ in cellular ...
  46. [46]
    Pulmonary carbonic anhydrase IV: developmental regulation and ...
    Pulmonary CA IV expression was found to be developmentally regulated, with a marked postnatal increase in mRNA content and immunoreactive protein concentration.
  47. [47]
    Small-molecule suppression of misfolding of mutated human ...
    Carbonic anhydrase II deficiency syndrome or Marble brain disease (MBD) is caused by autosomal recessive mutations in the human carbonic anhydrase II (HCA ...
  48. [48]
    Computational Discovery of Selective Carbonic Anhydrase IX (CA IX ...
    Aug 30, 2025 · In this study we designed a pharmacophore model based on known inhibitors to screen small compound libraries to discover potential inhibitors of ...
  49. [49]
    Crystal Structure of the “cab”-type β Class Carbonic Anhydrase from ...
    In higher plants, β-CAs play an important role in photosynthesis, by concentrating CO2 in the proximity of ribulose bisphosphate carboxylase/oxygenase for CO2 ...
  50. [50]
    Crystal structure of E. coli β–carbonic anhydrase, an enzyme with an ...
    The coordination of zinc by Asp 44 precludes carbonic anhydrase activity; yet mutagenesis studies of β-CAs support an essential role for Asp 44 in catalysis ( ...
  51. [51]
    Structure and catalytic mechanism of the β-carbonic anhydrases
    The enzyme catalyzes the rapid interconversion of CO2 and H2O to HCO3− and H+, and is believed to be associated with metabolic enzymes that consume or produce ...
  52. [52]
    Gamma Carbonic Anhydrase - Proteopedia, life in 3D
    Nov 26, 2019 · The main biological function of γ-carbonic anhydrase in M. thermophila is to catalyze the hydration of CO2 to HCO3- ion, in order to reduce the ...
  53. [53]
    Characterization of CamH from Methanosarcina thermophila ...
    The homotrimeric enzyme Mt-Cam from Methanosarcina thermophila is the archetype of the γ class of carbonic anhydrases.
  54. [54]
    A Structure−Function Study of a Proton Transport Pathway in the γ ...
    Four glutamate residues in the prototypic γ-class carbonic anhydrase from Methanosarcina thermophila (Cam) were characterized by site-directed mutagenesis ...
  55. [55]
    Biochemical characterization of the δ-carbonic anhydrase from the ...
    Recently we investigated for the first time the catalytic activity and inhibition of the δ-class CA from the marine diatom Thalassiosira weissflogii, named ...
  56. [56]
    Biochemical characterization of the δ-carbonic anhydrase ... - PubMed
    Jan 24, 2014 · Recently we investigated for the first time the catalytic activity and inhibition of the δ-class CA from the marine diatom Thalassiosira ...
  57. [57]
    Zeta-carbonic anhydrases show CS2 hydrolase activity - NIH
    Carbonic anhydrases (CAs) are ubiquitous metallo-enzymes that catalyze the reversible hydration of CO2 to bicarbonate ion and proton. These enzymes are present ...2.4. Cs Hydrolase Activity... · 3. Results · 3.3. Enzymatic Assays
  58. [58]
    Multi- and polypharmacology of carbonic anhydrase inhibitors
    Carbonic anhydrase inhibitors (CAIs) are used as diuretics, antiglaucoma, antiepileptic, antiobesity, and anti-acute mountain sickness drugs, with newer uses ...
  59. [59]
    Full article: New light on bacterial carbonic anhydrases phylogeny ...
    The zinc coordination pattern in the eta-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families.
  60. [60]
    An Overview of the Bacterial Carbonic Anhydrases - PMC
    Nov 11, 2017 · CAs are grouped into seven genetically distinct families, named α-, β-, γ-, δ-, ζ-, η-, and ɵ-CAs, with different folds and structures but ...
  61. [61]
    An overview on the recently discovered iota-carbonic anhydrases
    Iota-carbonic anhydrases (ι-CAs) are a recently discovered class of enzymes, first found in 2019, that differ in primary sequence from other CAs.
  62. [62]
    Full article: Bacterial ι-carbonic anhydrase: a new active class of ...
    Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii.
  63. [63]
    Genome Study of α-, β-, and γ-Carbonic Anhydrases from the ... - MDPI
    The CAs have been categorized into eight families. In this study, we focused on α-, β-, and γ-CAs from the thermophilic microbiome of marine hydrothermal vents.2. Materials And Methods · 3. Results · 3.2. Phylogenetic Analysis
  64. [64]
    Genomic and metagenomic survey of microbial carbonic anhydrase ...
    Jan 10, 2025 · Genomic and metagenomic survey of microbial carbonic anhydrase genes reveals novel clades, high diversity, and biome-specificity. View ORCID ...Missing: delta zeta eta iota extremophiles 2023 2024<|control11|><|separator|>
  65. [65]
  66. [66]
    Basolateral carbonic anhydrase IV in the proximal tubule ... - PubMed
    Carbonic anhydrase (CA) IV facilitates HCO(3) reabsorption in the renal proximal tubule by catalyzing the reversible hydration of CO(2).
  67. [67]
    Carbonic anhydrase versatility: from pH regulation to CO2 sensing ...
    Nov 9, 2023 · CA catalyzes the reversible interconversion between CO 2 and bicarbonate, effectively hydrating this metabolic gas, generated in oxidative processes in all ...
  68. [68]
    GPI-anchored carbonic anhydrase IV displays both intra - PNAS
    When human CA isoform IV was heterologously expressed in Xenopus oocytes, we observed, by measuring H+ at the outer face of the cell membrane and in the cytosol ...<|control11|><|separator|>
  69. [69]
    Biochemical, histological, and inhibitor studies of membrane ...
    Gastric acid secretion is dependent on carbonic anhydrase (CA). To define the role of membrane-bound CA, we used biochemical, histochemical, ...
  70. [70]
    Carbonic anhydrase, its inhibitors and vascular function - PubMed
    Jan 29, 2024 · Clinically employed CA inhibitors (CAIs) are used primarily to lower intraocular pressure in glaucoma, and also to affect retinal blood flow ...<|control11|><|separator|>
  71. [71]
    Carbon Dioxide Transport and Carbonic Anhydrase in Blood and ...
    To get there, CO2 diffuses from the intracellular space into the convective transport medium blood with the two compartments, plasma and erythrocytes. Within ...
  72. [72]
    Physiology, Carbon Dioxide Transport - StatPearls - NCBI Bookshelf
    In the lungs, this process reverses as both the HCO3-/Cl- exchanger and carbonic anhydrase enzyme reverse directions; this results in an influx of bicarbonate ...
  73. [73]
    CA4:Zn2+ dehydrates HCO3- to CO2 - Reactome Pathway Database
    CA4:Zn2+ dehydrates HCO3- to CO2. Stable Identifier. R ... Carbonic anhydrase IV dehydrates bicarbonate to water and carbon dioxide, H+ + HCO3- -> H2O + CO2.Missing: exhalation | Show results with:exhalation
  74. [74]
    (PDF) Comparison of blood carbonic anhydrase activity of athletes ...
    We observed a 50% increase in the blood CA activity at the second week after initiation of the training in both interval and continuos running groups, whereas ...
  75. [75]
    Respiratory and metabolic functions of carbonic anhydrase in ...
    Intracellular carbonic anhydrase (ICF CA) blockade elevated intracellular P ⁢ C O 2 P ⁢ CO 2 relative to untreated postexercise controls, whereas extracellular ...Missing: isoform upregulation
  76. [76]
    Reduction of carbonic anhydrase activity is associated ... - PubMed
    Reduction of carbonic anhydrase activity is associated with amelioration of obstructive sleep apnea. Sleep Breath. 2025 Sep 4;29(5):278.Missing: HCO3 | Show results with:HCO3
  77. [77]
    Arterial bicarbonate is associated with hypoxic burden and ...
    We recently demonstrated that daytime arterial standard bicarbonate ([HCO3-]) in patients with diagnosed OSA was increased along with sleep apnea severity [9].
  78. [78]
    How many carbonic anhydrase inhibition mechanisms exist?
    Five different CA inhibition mechanisms are known: (i) the zinc binders coordinate to the catalytically crucial Zn(II) ion from the enzyme active site.
  79. [79]
    Carbonic Anhydrase Inhibition with Sulfonamides ... - NIH
    Nov 20, 2021 · Carbonic Anhydrase Inhibition with Sulfonamides Incorporating Pyrazole- and Pyridazinecarboxamide Moieties Provides Examples of Isoform- ...
  80. [80]
    Anion inhibition of CO2 hydration catalyzed by human carbonic ...
    Five monovalent anions, I-, N3-, SCN-, NCO- and Au(CN)2-, were investigated as inhibitors of CO2 hydration catalyzed by human carbonic anhydrase II ...
  81. [81]
    Coumarin carbonic anhydrase inhibitors from natural sources - PMC
    Coumarins constitute a relatively new class of inhibitors of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), possessing a unique inhibition mechanism.
  82. [82]
    Synthetic strategies and medicinal chemistry perspectives of dual ...
    Dual acting inhibitors targeting carbonic anhydrases (CAs), monoamine oxidases (MAOs), and cholinesterases (ChEs) have emerged as promising therapeutic agents.
  83. [83]
    Synthesis, carbonic anhydrase inhibition studies and modelling ...
    Apr 12, 2024 · Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide-hydantoin hybrids. J Enzyme Inhib Med Chem. 2024 ...
  84. [84]
    Topical Carbonic Anhydrase Inhibitors - EyeWiki
    Sep 23, 2024 · Dosage: 1 drop 3 times daily when used alone or twice daily if being used in combination with other topical glaucoma treatment. Brinzolamide ...Background · Mechanism of Action (proposed) · Side effects
  85. [85]
    Pharmacological and ocular hypotensive properties of topical ...
    Dorzolamide and brinzolamide are two topical CA inhibitors which are currently available to treat ocular hypertension and/or glaucoma. Dorzolamide is a very ...
  86. [86]
    Systemic Carbonic Anhydrase Inhibitors in Common Ophthalmic ...
    Jul 8, 2025 · Systemic CAIs are valuable medications in congenital glaucoma cases to lower the IOP prior to surgery [57]. They effectively reduce the IOP by ...
  87. [87]
    Acetazolamide (Diamox): Uses & Side Effects - Cleveland Clinic
    It can be used with other medications to prevent and control seizures in people with epilepsy. It can also be used to prevent or treat symptoms of altitude ...
  88. [88]
    Acetazolamide: Uses, Interactions, Mechanism of Action - DrugBank
    Acetazolamide is a carbonic anhydrase inhibitor used to treat edema from heart failure or medications, certain types of epilepsy, and glaucoma.
  89. [89]
    Acetazolamide for the prophylaxis of migraine in CADASIL
    Feb 25, 2012 · There is no approved treatment for migraine prophylaxis in CADASIL, but acetazolamide has been anecdotally reported to be effective.
  90. [90]
    Acetazolamide Efficacy and Tolerability in Migraine With Aura: A ...
    Apr 5, 2005 · Acetazolamide has been reported as effective in migraine aura ... migraine patients compared to epileptic subjects. Clarification of ...
  91. [91]
    The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer ...
    Here, we demonstrate that the SLC-0111 CAIX inhibitor potentiates cytotoxicity of Dacarbazine and Temozolomide currently used for advanced melanoma treatment.
  92. [92]
    Addition of carbonic anhydrase 9 inhibitor SLC-0111 to ... - JCI Insight
    Dec 21, 2017 · We determined that SLC-0111 improves the efficacy of temozolomide to extend survival of GBM-bearing mice and should be explored as a treatment strategy.
  93. [93]
    A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic...
    Depletion of CAIX interferes with pH regulation, reduces cancer stem cells, inhibits epithelial mesenchymal transition and ultimately curtails tumor growth and ...<|separator|>
  94. [94]
    The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric ...
    Sep 1, 2023 · The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and ...
  95. [95]
    Carbonic anhydrase inhibition ameliorates tau toxicity via enhanced ...
    Carbonic anhydrase (CA) inhibitors protected against tau toxicity. CRISPR experiments confirmed that CA depletion mimicked the effects of these drugs.
  96. [96]
    Articles Sultiame once per day in obstructive sleep apnoea (FLOW)
    Oct 31, 2025 · Sultiame is a carbonic anhydrase inhibitor that improves ventilatory response and upper airway muscle tone, two mechanisms known to reduce sleep ...
  97. [97]
    Editorial: Emerging advancements in the carbonic anhydrase field
    Recent work here reviewed reveals that CA IX blockade unmasks metabolic co-vulnerabilities that sensitize cancer cells to cytotoxic agents by promoting ...
  98. [98]
    Dual targeting carbonic anhydrase inhibitors as promising ... - Frontiers
    Feb 2, 2025 · The dual-target inhibitor strategy is an evolving approach that holds great potential for treating complex diseases by addressing their multifactorial nature.Missing: polypharmacology | Show results with:polypharmacology
  99. [99]
    Carbonic Anhydrase Inhibitors - StatPearls - NCBI Bookshelf
    [8] Carbonic anhydrase inhibitor causes alkalization of urine, which is presumed to interact with the excretion of many medications.Indications · Administration · Adverse Effects · Contraindications
  100. [100]
    Side effects of acetazolamide: a systematic review and meta ...
    Apr 23, 2020 · The most common side effects of AZM are paraesthesias which may reduce therapy ... Reducing side effects of carbonic anhydrase inhibitors.Missing: diuresis | Show results with:diuresis
  101. [101]
    Acetazolamide: Considerations for Systemic Administration
    Mar 1, 2015 · The diuresis associated with acetazolamide may be temporary due to the high number of carbonic anhydrase enzymes in the kidneys; this may ...
  102. [102]
    Carbonic Anhydrase Inhibitors General Statement (Monograph)
    Paresthesia, characterized as numbness and a tingling sensation, may occur in the extremities, tongue, and/or the mucocutaneous junctions of the lips or the ...Uses · Dosage · Warnings
  103. [103]
    Improving carbon capture utilization and storage (CCUS)
    In addition, when CA was added at a concentration of 5.2 μM, a 10-fold increase in CO2 absorption to the uncatalyzed baseline was observed (Hu et al., 2017), ...
  104. [104]
    Directed evolution of an ultrastable carbonic anhydrase for highly ...
    Nov 3, 2014 · At pilot scale, the evolved catalyst enhanced the rate of CO2 absorption 25-fold compared with the noncatalyzed reaction. Sign up for PNAS ...
  105. [105]
    Veolia Uses Enzymes in World-First Trial to Remove CO2 with ...
    May 8, 2024 · Veolia aims to reduce the energy consumption, emissions and timescales for carbon removal by utilizing enzymes to accelerate the natural weathering process.
  106. [106]
    Discovery of a Highly Thermo- and Alkali-Stable Carbonic Anhydrase
    -increase of 0.01-0.03 °C for a value doubling the present concn. of ... Structural mechanics of the pH-dependent activity of β-carbonic anhydrase from.
  107. [107]
    [PDF] Global Carbon and Other Biogeochemical Cycles and Feedbacks
    In: Global. Warming of 1.5°C. An IPCC Special Report on the impacts of global warming of 1.5°C above pre-industrial levels and related global greenhouse gas.
  108. [108]
    Binding Dynamics of Biomimetic Zinc–Cyclen Ionic Liquid Catalyst ...
    Sep 30, 2025 · An alternative approach to catalytic hydrolysis of CO2 is presented, using a biomimetic Zn(II)cyclen system formulated with an ionic liquid ...
  109. [109]
    Advances in biomimetic carbonic anhydrase strategies for CO2 ...
    Jul 1, 2025 · Carbonic anhydrase (CA) enzymes hold strong potential in new biotechnological strategies for accelerated CO2 capture and conversion.
  110. [110]
    [PDF] Bifunctional Artificial Carbonic Anhydrase for the Integrated Capture ...
    The artificial CA [Zn(cyclen)]2+ increased the rate of capturing CO2 by 84% compared to control experiments and inhibited the HER (partial current density is ...
  111. [111]
    A closer look on the development and commercialization of ...
    The most studied applications of MC in recent literature are carbon capture and water desalination, while various other applications are getting increasing ...
  112. [112]
    WO2010151787A1 - Heat-stable carbonic anhydrases and their use
    These membranes are easy to scale-up to industrial scale and have been used in industry for wastewater treatment and beverage carbonation. A schematic ...
  113. [113]
    (PDF) Carbonic Anhydrases in Industrial Applications - ResearchGate
    Aug 6, 2025 · Due to CA's activity on CO2 there is increasing interest in using CAs for industrial applications such as carbon sequestration and biofuel ...
  114. [114]
    Directed evolution of an ultrastable carbonic anhydrase for highly ...
    After 9 rounds of evolution, a total of 36 positions representing 15% of the enzyme was mutated (Fig. 4A). Most of the mutations were located at the tetramer ...
  115. [115]
    Characterization of heterologously produced carbonic anhydrase ...
    The enzyme purified from E. coli has properties (specific activity, inhibitor sensitivity, and thermostability) similar to those of the authentic enzyme ...
  116. [116]
    Carbonic Anhydrase Immobilized by ZnO Nanoparticles for Catalytic ...
    Aug 6, 2025 · Here, we review the use of carbonic anhydrase nanobiocatalysts for carbon dioxide sequestration, with emphasis on inorganic, organic, and ...
  117. [117]
  118. [118]
    Electroenzymatic CO2 Reduction Using Dual Enzymes ...
    May 29, 2025 · Formate dehydrogenase (FDH) and carbonic anhydrase (CA) are co-encapsulated within the Zn-MOF-74 framework to create a dual enzyme cascade system.